Where does Ganeden Biotech, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ganeden Biotech, Inc. ranks #14,633 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ganeden Biotech, Inc. hold?

Ganeden Biotech, Inc. holds 20 US utility patents granted between 2015 and 2023, spanning 11 technology areas.

What is Ganeden Biotech, Inc.'s Innovation Score?

Ganeden Biotech, Inc. has an Innovation Score of 54.6 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ganeden Biotech, Inc.'s patent grant rate increasing or decreasing?

Ganeden Biotech, Inc.'s recent grant velocity is -46% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ganeden Biotech, Inc.'s patents?

Ganeden Biotech, Inc.'s patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ganeden Biotech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ganeden Biotech, Inc.

Q: What technology areas does Ganeden Biotech, Inc. focus on?

Ganeden Biotech, Inc.'s top technology area is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof) with 17 patents, ranking #80 of 1,325 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 11 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ganeden ranks #14,633 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 11 technology areas.

#14,633
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.6/100): 20.6
avg claims per patent: -46%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14633 · US Corporation #14,633 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,633/49,997
PHOTO-FINISH Genesis
CPC-FOCUS A23L · 11 areas
INNOV-PAR 54.6/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -46% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genesis Technologies Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ganeden’s 54.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (19%) Velocity 20.0 pts (37%) Breadth 11.7 pts (21%) Claim depth 12.4 pts (23%)

Qualcomm Incorporated · highest

85
Ganeden Biotech · this assignee

55
3D Lighting… · lowest

7

What this shows Ganeden's Innovation Score is 54.6/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ganeden?

Each dot is one of Ganeden’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ganeden’s own 20.6 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ganeden vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ganeden's grants concentrate

Ganeden Biotech, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 85% of grants classified under A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2023. By volume, Ganeden sits between Graphene Square Inc. and Geobrugg AG.

Ganeden's three-year grant acceleration

Ganeden Biotech, Inc. shows 7 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Graphene Square

20
Green Idea Tech

20
Guangdong Welling…

20
Guangzhou Alpha C…

20
Genesis

20
Genomic Health

20
Genpact Luxembour…

20
Geobrugg

20
Ganeden Biotech ◀

20

What this shows Ganeden holds 20 patents at rank #14,644, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ganeden

By rank, the assignees closest to #14,644 in granted patent volume.

Leaders in A23L (Foods)

Other assignees with the most granted patents in Ganeden's primary technology class.

Ganeden's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ganeden Biotech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	10.0%
2016	2	10.0%
2017	3	15.0%
2018	4	20.0%
2019	2	10.0%
2022	6	30.0%
2023	1	5.0%

Which technologies does Ganeden Biotech, Inc. patent most?

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 17

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 14

A23G - COCOA; Cocoa Products, e.g. CHOCOLATE; Substitutes FOR Cocoa OR Cocoa PRODUCTS; CONFECTIONERY; Chewing GUM; ICE-CREAM; Preparation Thereof 6

A23D - Edible Oils OR Fats, e.g. Margarines, Shortenings OR Cooking Oils 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A23K - Fodder 2

A21D - Treatment OF Flour OR Dough FOR Baking, e.g. BY Addition OF MATERIALS; BAKING; Bakery Products 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

A23P - Shaping OR Working OF Foodstuffs, NOT Fully Covered BY A Single Other Subclass 2

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ganeden Biotech, Inc.'s patent record in context - here's where to go next.

Ganeden Biotech, Inc.'s lead technology class is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof), 85% of its portfolio - see every assignee active in that class. Explore A23L
Ranked #14,633 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ganeden Biotech, Inc. against Graphene Square Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.